at Zacks.com (Nov 17, 2014)
There are no Focus articles on CLTX.
There are no Transcripts on CLTX.
We currently have no Breaking News on this stock.
CLTX vs. ETF Alternatives
Celsus Therapeutics PLC is a development stage company. The Company is engaged in the development of ethical synthetic drugs for the treatment of severe chronic inflammatory conditions such as contact dermatitis, etc.
Other News & PR